Tamura H, Iida T, Watanabe T, Suga T
Department of Clinical Biochemistry, Tokyo College of Pharmacy, Japan.
Toxicology. 1990 Aug;63(2):199-213. doi: 10.1016/0300-483x(90)90043-g.
In order to clarify whether peroxisomal hydrogen peroxide (H2O2) plays an important role in peroxisome proliferator-induced hepatocarcinogenesis, we examined the change in metabolism of peroxisomal H2O2 in vivo and in vitro using male Fischer-344 rats fed clofibrate, bezafibrate and di(2-ethylhexyl)phthalate (DEHP) for up to 78 weeks. Hepatic peroxisomal fatty acyl-CoA oxidase activity increased 12-20-fold after 2 or 4 weeks treatment; later this level gradually decreased toward controls, and at 78 weeks activity was 3-10-times of control. Although hepatic H2O2 levels were increased slightly by clofibrate, bezafibrate and DEHP, the changes did not correlate with the changes in peroxisomal fatty acyl-CoA oxidase activity. In isolated hepatocytes, the rate of leakage of peroxisomal H2O2 from peroxisomes into the cytosol and the hepatocellular H2O2 content was measured. The rate of leakage of peroxisomal H2O2 into cytosol increased 2.5-4-fold when peroxisomal beta-oxidation activity was induced by peroxisome proliferators, and the increases in this rate corresponded with changes in the peroxisomal beta-oxidation activity. In contrast, the hepatocellular H2O2 contents were not affected by induced peroxisomal beta-oxidation. These data show that H2O2 leaking from peroxisome into cytosol would be quickly decomposed, and thus peroxisomal H2O2 does not appear to play an important role in hepatocarcinogenesis by such an oxidative stress mechanism after the long-term treatment with peroxisome proliferators.
为了阐明过氧化物酶体过氧化氢(H2O2)在过氧化物酶体增殖剂诱导的肝癌发生中是否起重要作用,我们使用喂食氯贝丁酯、苯扎贝特和邻苯二甲酸二(2-乙基己基)酯(DEHP)长达78周的雄性Fischer-344大鼠,检测了体内和体外过氧化物酶体H2O2代谢的变化。治疗2或4周后,肝脏过氧化物酶体脂肪酰辅酶A氧化酶活性增加了12至20倍;随后该水平逐渐降至对照水平,在78周时活性是对照的3至10倍。尽管氯贝丁酯、苯扎贝特和DEHP使肝脏H2O2水平略有升高,但这些变化与过氧化物酶体脂肪酰辅酶A氧化酶活性的变化无关。在分离的肝细胞中,测量了过氧化物酶体H2O2从过氧化物酶体泄漏到细胞质中的速率以及肝细胞H2O2含量。当过氧化物酶体增殖剂诱导过氧化物酶体β-氧化活性时,过氧化物酶体H2O2泄漏到细胞质中的速率增加了2.5至4倍,并且该速率的增加与过氧化物酶体β-氧化活性的变化相对应。相反,肝细胞H2O2含量不受诱导的过氧化物酶体β-氧化的影响。这些数据表明,从过氧化物酶体泄漏到细胞质中的H2O2会迅速分解,因此在长期用过氧化物酶体增殖剂治疗后,过氧化物酶体H2O2似乎不会通过这种氧化应激机制在肝癌发生中起重要作用。